Prognosis after CBT in each group of the conditioning regimen. (A) HDCA/CY/TBI showed significantly better OS than CY/TBI after being adjusted for confounding factors such as patient sex, age, PS, CMV serostatus, disease risk, pretransplant therapy period, HLA mismatch, and ABO mismatch (P < .01). (B) Tumor-related mortality, defined as death without remission or after relapse, was significantly higher in the CY/TBI group (P < .01 adjusted for the above-mentioned confounding factors). (C) NRM showed no significant differences between the 2 groups.